OXFORD BIODYNAMICS LS-01
Research OXFORD BIODYNAMICS LS-01 (LMQ) on Bullrun: market cap EUR 2.15M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLMQ
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 2.15M
- Financial periodFY2025
- RevenueEUR 1.10M
- Revenue growth72.2%
- Net income-EUR 11.15M
- Free cash flow-EUR 7.82M
- Gross margin47.7%
Valuation Snapshot
latest market cap is EUR 2.15M.
About OXFORD BIODYNAMICS LS-01
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy.
Frequently asked questions
What is OXFORD BIODYNAMICS LS-01's market cap?
OXFORD BIODYNAMICS LS-01's market capitalization is EUR 2.15M.
What does OXFORD BIODYNAMICS LS-01 do?
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom.